Climate change is expanding the range of mosquito-borne diseases such as yellow fever, making outbreaks more frequent, unpredictable, and difficult to contain. At a roundtable hosted and sponsored by Sanofi, global health leaders and innovators discussed how innovation can transform the way yellow fever vaccines are produced and delivered to ensure faster and more sustainable access to vaccines.
The agent mentioned here is investigational and has not been approved by the U.S. Food and Drug Administration, or FDA, or any other regulatory agency worldwide. No conclusions regarding safety and efficacy should be drawn for such agent.
Visit Sanofi’s website to learn more.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Devex Partnerships
Thanks for reading and for your interest in Devex. In collaboration with our partners, Devex’s partnerships editorial team produces content to promote a partner’s work or perspectives on a particular issue. It gives actors across the global development sector — including nongovernmental organizations, private sector stakeholders, aid agencies and government institutions — the opportunity to go beyond traditional advertising and tell their stories in an impactful way. If you’d like to learn more about how you can shine a spotlight on a particular issue with Devex, please email partnerships@devex.com. We look forward to hearing from you.